WHO Priority Interventions for Strengthening Wilms Tumor Care

​

In 2026, the World Health Organization (WHO) published Priority Interventions to Strengthen Service Delivery for Wilms Tumour: Global Initiative for Childhood Cancer Technical Brief. The report provides practical, evidence-informed guidance for countries seeking to improve the organization, financing and delivery of healthcare services for children diagnosed with Wilms tumor.

​

The technical brief identifies seven priorities covering the complete Wilms tumor care pathway:

​

1. Reducing delayed diagnosis through early detection

2. Improving access to diagnosis and staging

3. Improving access to quality treatment

4. Preventing abandonment of treatment

5. Providing access to adequate supportive care

6. Achieving an integrated palliative care approach

7. Ensuring the provision of survivorship care

​

The report is principally intended for policymakers, hospital managers, childhood cancer leaders and national cancer control program managers. However, its recommendations also have direct importance for children, parents, caregivers, healthcare professionals, researchers, patient advocates and organizations working to improve childhood kidney cancer outcomes.

​

By bringing together current evidence, international expertise and practical health-system considerations, WHO provides countries with a framework that can be adapted to different populations, healthcare structures and levels of available resources.

​

​About the WHO Wilms Tumor Technical Brief

​

The 2026 WHO Wilms tumor technical brief is the first in a series addressing the six index cancers included within the

WHO Global Initiative for Childhood Cancer (GICC).

​

The report was developed to help countries determine which services, healthcare professionals, equipment, medicines,

referral systems and financial protections are needed to provide high-quality Wilms tumor care.

​

It addresses the entire childhood cancer pathway, including:

​

• Public awareness and early detection

• Primary healthcare assessment

• Referral to specialist services

• Diagnostic imaging

• Pathology and tumor staging

• Multidisciplinary treatment

• Surgery, chemotherapy and radiation therapy

• Prevention of treatment abandonment

• Nutrition and supportive care

• Pediatric palliative care

• Surveillance and survivorship

• Monitoring and evaluation

 

Rather than prescribing a single treatment protocol for every country, the report focuses on the organization of services. Each WHO Member State is encouraged to adapt the priority interventions to its available resources, healthcare capacity and existing childhood cancer programs.

​

The technical brief is aligned with the WHO CureAll framework and can support the inclusion of childhood cancer within national cancer control plans, essential health-service packages and universal health coverage programs.

​

Why the WHO Report Matters

​

Wilms tumor, also known as nephroblastoma, is a cancerous kidney tumor that mainly affects young children. The WHO report identifies it as the fourth most common type of childhood cancer and states that approximately 75% of cases occur in children younger than five years.

​

Wilms tumor is highly curable when children receive timely diagnosis and appropriate multidisciplinary treatment. The report notes that five-year survival rates now exceed 85%.

​

However, global survival figures can conceal substantial inequalities.

​

Children living in lower-resource healthcare settings may experience:

​

• Limited awareness of childhood cancer symptoms

• Delayed access to primary healthcare

• Slow or ineffective referral pathways

• Limited diagnostic imaging

• Inadequate pathology services

• Shortages of trained pediatric cancer professionals

• Restricted access to surgery or radiation therapy

• Interruptions in essential chemotherapy supplies

• Financial and geographical barriers

• Treatment abandonment

• Limited supportive, palliative and survivorship care

 

These barriers mean that a highly treatable disease can still result in preventable deaths.

​

The report therefore considers more than the effectiveness of individual treatments. It examines how healthcare systems must be organized so that children can reach the right services, receive an accurate diagnosis, complete treatment and obtain appropriate long-term care.

​

Wilms Tumor as a WHO Index Cancer

​

Wilms tumor is one of six childhood cancers selected as initial index cancers for the WHO Global Initiative for Childhood Cancer.

​

An index cancer can be used to assess whether a healthcare system has the essential services required to diagnose and treat childhood cancer effectively. Because Wilms tumor treatment depends on coordinated care across several medical specialties, strengthening its care pathway can also improve wider pediatric oncology services.

​

High-quality Wilms tumor care may require:

​

• Trained primary and community healthcare professionals

• Efficient referral to specialist pediatric cancer centers

• Diagnostic radiology

• Pathology and laboratory medicine

• Pediatric oncology

• Pediatric surgery or urology

• Safe anesthesia

• Chemotherapy

• Radiation therapy

• Nursing and pharmacy

• Infection control and blood transfusion services

• Nutrition and supportive care

• Psychological and social support

• Pediatric palliative care

• Long-term survivorship services

 

If any part of this pathway is unavailable or poorly coordinated, children may experience delayed treatment, avoidable complications or poorer outcomes.

Wilms tumor therefore provides an important measure of whether national childhood cancer services are accessible, coordinated and capable of delivering complex multidisciplinary care.

​

The Seven WHO Priority Interventions

​

The seven interventions follow the journey of a child with Wilms tumor from the first recognition of possible symptoms through diagnosis, treatment, recovery, survivorship or palliative care.

​

Each priority includes system-level considerations and questions that governments and healthcare leaders can use to evaluate existing services.

Together, the interventions emphasize four central principles:

​

• Children must be diagnosed promptly and accurately.

• Effective treatment must be available, affordable and completed.

• Children and families must receive supportive and palliative care when required.

• Survivorship and long-term health must be planned from the beginning.

​

1. Reducing Delayed Diagnosis Through Early Detection

 

Early and accurate diagnosis is essential to improving childhood cancer outcomes.

​

Wilms tumor may initially cause few symptoms other than an abdominal mass. A parent or caregiver may notice a firm lump or swelling while bathing, dressing or holding the child. A healthcare professional may also identify the mass during a routine physical examination.

​

Other possible Wilms tumor symptoms include:

​

• Abdominal swelling or pain

• Blood in the urine

• High blood pressure

• Fever

• Nausea

• Loss of appetite

• Constipation

• Shortness of breath

• Pallor or tiredness

• A rapidly growing abdominal mass

 

These symptoms can have many causes and do not necessarily mean that a child has cancer. However, persistent or concerning symptoms should be assessed by a qualified healthcare professional.

​

The WHO report identifies several barriers that can delay diagnosis:

​

• Limited awareness among parents and communities

• Low childhood cancer health literacy

• Cancer-related fear or stigma

• Restricted access to primary care

• Failure to recognize warning signs

• Delays in diagnostic testing

• Poorly coordinated referral systems

• Financial or geographical obstacles

 

WHO recommends strengthening public awareness, improving frontline healthcare training and creating clear referral pathways to specialist pediatric oncology services.

​

Healthcare professionals at the first point of contact must know when to suspect childhood cancer and how to refer children quickly. Families must also receive clear communication that helps them understand the urgency of further tests without causing unnecessary alarm.

​

2. Improving Access to Diagnosis and Staging

​

Once Wilms tumor is suspected, timely access to diagnostic and staging services is essential.

​

An accurate diagnosis allows the medical team to determine whether the mass is Wilms tumor or another condition. Staging establishes the extent of the disease and helps guide treatment.

​

The diagnostic process may involve:

​

• Clinical history and examination

• Assessment of the abdominal mass

• Blood pressure measurement

• Blood tests

• Urinalysis

• Abdominal ultrasound

• CT or MRI of the abdomen and pelvis

• Chest imaging to look for possible lung metastases

• Surgical assessment

• Histopathological examination

• Tumor risk classification

• Genetic assessment when a predisposition syndrome is suspected

 

The WHO report emphasizes that accurate staging combines clinical, radiological, laboratory, pathological and surgical information.

​

In many low- and middle-income countries, diagnostic services remain a major barrier. Healthcare facilities may have limited access to CT or MRI imaging, pediatric anesthesia, trained radiologists, specialist pathology or reliable laboratory systems.

​

Strengthening Wilms tumor diagnosis therefore requires investment in:

​

• Essential imaging equipment

• Pathology and laboratory infrastructure

• Safe pediatric anesthesia

• Workforce training

• Standardized specimen handling

• Quality-assurance systems

• Clear diagnostic protocols

• Rapid communication of results

• Coordinated referral between hospitals

 

Accurate diagnosis and staging reduce the risks of inappropriate treatment, unnecessary delays and avoidable exposure to therapies that a child may not require.

​

3. Improving Access to Quality Treatment

​

Wilms tumor treatment commonly involves surgery and chemotherapy. Radiation therapy may also be required depending on the tumor’s stage, histology, treatment protocol and whether the cancer has spread.

​

Treatment approaches differ internationally. Some protocols begin with chemotherapy before surgery, while others begin with removal of the affected kidney. Both approaches require specialist multidisciplinary planning.

​

Quality Wilms tumor treatment depends on access to:

​

• Pediatric oncology specialists

• Pediatric surgeons or urologists

• Safe surgical and anesthesia services

• Essential chemotherapy medicines

• Radiation oncology where clinically required

• Trained pediatric oncology nurses

• Pharmacy services

• Blood transfusion and laboratory support

• Infection prevention and treatment

• Nutrition and supportive care

• Psychological and social support

• Monitoring of treatment response and toxicity

 

The WHO report highlights the importance of standardized treatment regimens, reliable supplies of medicines and diagnostic devices, and coordinated care networks.

​

Countries should establish national standards that reflect recognized evidence while remaining feasible within their healthcare environments. Treatment protocols must also be supported by the services required to deliver them safely.

​

Providing chemotherapy without infection management, surgery without appropriate anesthesia or radiation therapy without effective quality assurance can place children at unnecessary risk.

​

Quality care therefore means delivering the complete package of services required to support each child’s treatment.

​

4. Preventing Treatment Abandonment

​

Treatment abandonment occurs when a child does not begin or complete treatment intended to cure the cancer.

​

It is a major cause of avoidable childhood cancer deaths in some lower-resource settings. A treatment plan cannot succeed if families are unable to reach the hospital, afford associated costs or remain engaged throughout care.

​

Reasons for treatment abandonment may include:

​

• Medical expenses

• Transportation costs

• Long journeys to specialist centers

• Accommodation requirements

• Loss of parental income

• Food insecurity

• Responsibilities for other children

• Limited understanding of treatment

• Fear of chemotherapy or surgery

• Cancer stigma or misinformation

• Poor communication with healthcare teams

• Weak patient-tracking systems

 

The WHO report identifies several approaches that can improve treatment completion:

​

• Financial assistance for families

• Transportation support

• Food subsidies

• Family accommodation near treatment centers

• Parent and caregiver education

• Social work services

• Patient navigation

• Mobile tracking and follow-up systems

• Psychological and peer support

• Clear communication about the treatment plan

 

Preventing abandonment requires governments and hospitals to recognize the indirect costs carried by families. Even where medical treatment is publicly funded, travel, accommodation, food and lost income can make continued attendance impossible.

​

Family support must therefore be treated as part of the healthcare system rather than as an optional charitable addition.

​

5. Providing Access to Adequate Supportive Care

​​

Supportive care helps children manage cancer symptoms, treatment side effects and medical complications.

​

It can determine whether a child is able to receive treatment safely and complete the prescribed therapy.

​

Supportive care may include:

​

• Infection prevention and management

• Antibiotics and other essential medicines

• Blood products and transfusion services

• Pain and symptom control

• Nutrition assessment and intervention

• Hydration support

• Management of nausea and vomiting

• Oral and dental care

• Psychological support

• Rehabilitation

• Social work assistance

• Family education

• Support for siblings and caregivers

 

Nutrition is particularly important because malnutrition can affect treatment tolerance, recovery and overall health. Children presenting with large tumors or advanced disease may already be nutritionally vulnerable.

​

The WHO report also emphasizes communication. Families must understand the treatment plan, possible side effects, warning signs requiring urgent care and how to access help between hospital appointments.

​

Adequate supportive care recognizes that treating Wilms tumor involves caring for the whole child and supporting the family throughout the treatment journey.

​

6. Achieving an Integrated Palliative Care Approach

​

Pediatric palliative care is an important component of comprehensive childhood cancer care.

​

It should not be understood only as care provided at the end of life. Palliative care can be introduced alongside disease-directed treatment to manage pain and other symptoms, support communication and improve quality of life.

​

An integrated approach may include:

​

• Age-appropriate symptom assessment

• Pain management

• Management of nausea, breathing difficulties and constipation

• Psychological and emotional care

• Communication about treatment goals

• Support for parents, caregivers and siblings

• Culturally and spiritually appropriate care

• Assistance with practical family needs

• Community or home-based services

• End-of-life care when treatment can no longer achieve a cure

 

The WHO report stresses the importance of including children and families in decision-making in ways that are appropriate for the child’s age, development, culture and circumstances.

​

It also reinforces that families should never feel abandoned when the goals of treatment change. Compassionate communication and continuity of care remain essential throughout every stage of illness.

​

7. Ensuring the Provision of Survivorship Care

​

Survivorship care begins when treatment ends, but planning for long-term health should start much earlier.

​

The WHO report states that chronic health problems occur in nearly 25% of long-term Wilms tumor survivors. The likelihood and type of late effects depend on factors including surgery, chemotherapy exposure, radiation treatment, the extent of disease and the child’s individual health needs.

​

Wilms tumor survivors may require monitoring of:

​

• Remaining kidney function

• Blood pressure

• Heart health

• Lung function

• Growth and development

• Hormonal health

• Fertility and reproductive health

• Bone and musculoskeletal health

• Hearing where relevant

• Emotional and psychological wellbeing

• Educational and social development

• Tumor recurrence

• Second cancer risks

• Transition to adult healthcare

 

Survivorship services should provide an individualized treatment summary and long-term follow-up plan wherever possible. Survivors and families need to understand which health checks are recommended and why ongoing monitoring remains important.

​

The report recognizes survivorship as an essential element of cancer care rather than an optional service available only in well-resourced healthcare systems.

 

Supporting the WHO Global Initiative for Childhood Cancer

​

The WHO Global Initiative for Childhood Cancer was created to improve childhood cancer survival and reduce suffering worldwide.

​

Its objectives extend beyond individual diseases. The Initiative helps governments strengthen health systems, improve access to diagnosis and treatment, develop trained workforces and incorporate childhood cancer within national health priorities.

​

The Wilms tumor technical brief supports these objectives by providing a practical framework that countries can apply to one of the GICC index cancers.

​

Its recommendations contribute to:

​

• Earlier and more accurate diagnosis

• Accessible, high-quality treatment

• Stronger multidisciplinary teams

• Reduced treatment abandonment

• Improved supportive and palliative care

• Structured survivorship services

• Better monitoring and evaluation

• More equitable childhood cancer outcomes

 

Progress in these areas can strengthen the wider pediatric oncology system and benefit children diagnosed with other cancers.

​

The WHO CureAll Framework and Wilms Tumor

​

The technical brief is aligned with the CureAll operational framework, which helps countries translate the objectives of the Global Initiative for Childhood Cancer into practical healthcare action.

​

For Wilms tumor, the framework supports:

​

Centers of Excellence and Care Networks

​

Children should be connected with appropriately trained specialists through coordinated regional and national referral networks.

​

Universal Health Coverage

​

Essential childhood cancer diagnosis, treatment and supportive services should be included within healthcare benefit packages, with financial protection for families.

​

Standardized Treatment Regimens

​

Countries should develop and implement evidence-based national standards supported by reliable access to essential medicines, diagnostics and medical devices.

​

Evaluation and Monitoring

​

Health systems need accurate information about diagnosis, treatment completion, survival, abandonment and long-term outcomes to identify gaps and measure progress.

​

Together, these areas provide the infrastructure required to turn clinical knowledge into accessible, consistent and sustainable care.

​

How the WHO Report Aligns with WCF Initiatives

​

The seven WHO priorities closely align with the work of the Wilms Cancer Foundation and its flagship Global Wilms Tumor Initiative™.

​

WCF’s international programs focus on:

​

• Increasing awareness of Wilms tumor symptoms

• Supporting earlier recognition and diagnosis

• Expanding access to trusted information

• Educating parents and caregivers

• Supporting healthcare professional knowledge

• Addressing global inequalities in care

• Promoting treatment completion and family support

• Improving survivorship education

• Translating evidence into practical resources

• Encouraging international collaboration

 

The Foundation’s programs and platforms include:

​

• Global Wilms Tumor Initiative™

• Wilms Tumor Knowledge Index™

• Wilms Tumor WebApp

• Wilms Tumor AI Support Service

• Global Educational Library

• Complete Guide to Wilms Tumor

• International educational literature

• Multilingual parent and caregiver resources

• Healthcare professional briefings

• International webinars and knowledge-sharing programs

 

WCF can help translate the WHO’s health-system recommendations into accessible explanations for different audiences. This includes helping families understand why earlier diagnosis matters, explaining the services required for quality treatment and raising awareness of supportive care, treatment abandonment and survivorship.

​

The Foundation’s role is educational and advocacy-focused. Decisions about national implementation, funding and clinical practice remain the responsibility of governments, healthcare systems and qualified medical professionals.

​

Benefits for Children and Families

​

Although the WHO technical brief is written primarily for decision-makers, its successful implementation could directly improve the experience of children and families.

​

Potential benefits include:

​

• Greater public awareness of Wilms tumor symptoms

• Faster assessment and specialist referral

• Improved access to diagnostic imaging and pathology

• More accurate diagnosis and staging

• Coordinated multidisciplinary treatment

• Reliable access to essential medicines

• Financial and practical assistance

• Better nutrition and supportive care

• Clearer communication from healthcare professionals

• Reduced treatment interruption and abandonment

• Integrated palliative care when required

• Structured survivorship and long-term follow-up

 

For parents and caregivers, improved services can reduce the burden of navigating fragmented healthcare systems. Clear referral pathways, patient navigation and understandable information can help families know where to go, what to expect and whom to contact when concerns arise.

​

The report also recognizes that parents need appropriate information about symptoms, treatment, side effects and long-term health. Families should be supported as active participants in care while receiving individualized medical guidance from qualified professionals.

​

Benefits for Healthcare Professionals

​

The report provides healthcare professionals with a structured view of the services required across the Wilms tumor pathway.

​

For frontline and primary healthcare professionals, it reinforces the importance of:

​

• Recognizing possible childhood cancer symptoms

• Assessing abdominal masses appropriately

• Measuring blood pressure

• Understanding cancer-predisposition conditions

• Making timely referrals

• Communicating effectively with families

 

For specialist teams, the report emphasizes:

​

• Multidisciplinary treatment planning

• Accurate imaging and pathology

• Standardized staging

• Safe surgery, chemotherapy and radiation therapy

• Supportive and palliative care

• Nutrition and psychosocial support

• Survivorship planning

• Monitoring treatment completion and outcomes

 

The guidance can also help hospital leaders identify workforce and infrastructure gaps, develop referral networks and plan professional education.

​

Benefits for Researchers

​

The WHO report highlights the limited evidence available for organizing Wilms tumor services in resource-constrained settings.

​

Many clinical guidelines are based largely on experience from high-income countries. Further research is needed to determine how treatment and service-delivery approaches can be implemented safely and effectively in countries with fewer resources.

​

Priority research areas include:

​

• Feasible Wilms tumor treatment in lower-resource settings

• Diagnostic pathways and referral delays

• Treatment abandonment and adherence

• Financial and socioeconomic barriers

• Nutrition and supportive care

• Long-term treatment effects

• Survivorship and quality of life

• Health-system implementation

• Workforce and infrastructure development

• Global differences in childhood kidney cancer outcomes

 

Researchers should consider not only whether a treatment is clinically effective, but also whether it is accessible, affordable and deliverable within different healthcare environments.

​

WCF supports knowledge translation by helping communicate research findings to families, healthcare professionals, advocates and policymakers.

​

Benefits for Governments

​

The report gives governments and national cancer programs a practical framework for assessing childhood cancer services.

​

It can inform:

​

• National cancer control strategies

• Childhood cancer implementation plans

• Universal health coverage packages

• Pediatric oncology workforce development

• Centers of excellence and regional networks

• Diagnostic imaging and pathology investment

• Procurement of essential medicines and devices

• Financial protection for families

• Patient navigation and tracking

• Nutrition and supportive-care services

• Pediatric palliative care

• Survivorship programs

• Cancer registries and outcome monitoring

 

Governments can use the seven interventions to identify service gaps, establish priorities and plan context-appropriate investments.

Improving Wilms tumor services can also produce benefits across the wider health system by strengthening referral networks, diagnostics, surgery, medicine supply, supportive care and long-term monitoring.

​

Global Wilms Tumor Programme Delivery

​

The WHO report recognizes that countries have different resources, infrastructure and childhood cancer capacity. Implementation must therefore be adapted to local circumstances while continuing to work toward safe, equitable and evidence-based care.

​

WCF’s international program delivery can support this process through:

​

• Wilms tumor awareness campaigns

• Parent and caregiver education

• Healthcare professional resources

• Multilingual educational literature

• Country- and region-specific information

• Digital access through the Wilms Tumor WebApp

• Knowledge organization through the Wilms Tumor Knowledge Index™

• International webinars and professional engagement

• Global advocacy and research communication

 

Priority regions include areas where access to Wilms tumor information, specialist pediatric oncology services or survivorship care remains limited.

Through collaboration with healthcare professionals, cancer organizations and international institutions, WCF aims to make educational resources relevant to the needs of different countries and communities.

​

Future Global Collaboration

​

Publication of the WHO technical brief creates an opportunity for governments, healthcare providers, professional societies, researchers, patient organizations and international agencies to coordinate their efforts around a shared set of priorities.

​

Future collaboration should focus on:

​

• Translating the report into national action

• Assessing local childhood cancer services

• Strengthening referral and diagnostic pathways

• Training healthcare professionals

• Expanding access to essential medicines and treatment

• Reducing the financial burden on families

• Preventing treatment abandonment

• Improving supportive and palliative care

• Developing survivorship programs

• Conducting research in resource-limited settings

• Monitoring implementation and outcomes

• Sharing successful approaches internationally

 

WCF will continue raising awareness of the report and translating its recommendations into practical educational content through the Global Wilms Tumor Initiative™.

​

The publication itself is an important international milestone. Its lasting impact, however, will depend on implementation—turning written recommendations into trained teams, accessible services, family support and measurable improvements in survival and quality of life for children with Wilms tumor worldwide.

​

About the WHO Technical Brief

​

Title: Priority Interventions to Strengthen Service Delivery for Wilms Tumour: Global Initiative for Childhood Cancer Technical Brief

Publisher: World Health Organization
Publication year: 2026
Electronic ISBN: 978-92-4-012325-0
Print ISBN: 978-92-4-012326-7

 

The report is intended to support policymakers, hospital managers, childhood cancer focal points and cancer control program managers responsible for planning, financing and coordinating pediatric oncology services.

Its recommendations should be adapted to each country’s healthcare structure, resources, policies and clinical context.